These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21375136)

  • 1. A regular or an intermittent treatment for asthma: the long-term effect.
    Sposato B; Pammolli A; Bove L; Barzan R; Ricci A; Scalese M; Marioita S; Franco C
    Eur Rev Med Pharmacol Sci; 2010 Dec; 14(12):1037-44. PubMed ID: 21375136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary function in symptom-free asthmatics.
    Yaacob I; Mohammad M
    Singapore Med J; 1993 Dec; 34(6):522-3. PubMed ID: 8153715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K; Noonan M; Silkoff PE; Uryniak T
    Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-year changes in airflow obstruction and airway responsiveness in mild to moderate asthma.
    Boulet LP; Jobin C; Milot J; Turcotte H
    Clin Invest Med; 1994 Oct; 17(5):432-42. PubMed ID: 7867248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do current treatment protocols adequately prevent airway remodeling in children with mild intermittent asthma?
    Bibi HS; Feigenbaum D; Hessen M; Shoseyov D
    Respir Med; 2006 Mar; 100(3):458-62. PubMed ID: 16046260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early intervention with inhaled corticosteroids in subjects with rapid decline in lung function and signs of bronchial hyperresponsiveness: results from the DIMCA programme.
    den Otter JJ; van Schayck CP; Folgering HT; van den Boom G; Akkermans RP; van Weel C
    Eur J Gen Pract; 2007; 13(2):89-91. PubMed ID: 17534745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma.
    Kuna P; Creemers JP; Vondra V; Black PN; Lindqvist A; Nihlen U; Vogelmeier C
    Respir Med; 2006 Dec; 100(12):2151-9. PubMed ID: 16701989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of spirometry and impulse oscillometry in relation to asthma control.
    Manoharan A; Anderson WJ; Lipworth J; Lipworth BJ
    Lung; 2015 Feb; 193(1):47-51. PubMed ID: 25516285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Observational study of the natural history of eosinophilic bronchitis.
    Berry MA; Hargadon B; McKenna S; Shaw D; Green RH; Brightling CE; Wardlaw AJ; Pavord ID
    Clin Exp Allergy; 2005 May; 35(5):598-601. PubMed ID: 15898981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of lung volume measurements by plethysmography in the follow-up of asthma in children].
    Labbé G; Merlin E; Kauffman C; Fauquert JL; Héraud MC; Labbé A
    Rev Mal Respir; 2010; 27(1):42-8. PubMed ID: 20146951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung function in asthma: relation to clinics, challenge tests and immunotherapy.
    Palma-Carlos AG; Palma-Carlos ML
    Eur Ann Allergy Clin Immunol; 2003 Jun; 35(6):195-8. PubMed ID: 12872676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. True restrictive ventilatory pattern in asthma.
    Rothe T
    J Asthma; 2010 Jun; 47(5):594-6. PubMed ID: 20536282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical significance of volume-adjusted maximal mid-expiratory flow (Iso-volume FEF25-75%) in assessing airway responsiveness to inhaled bronchodilator in asthmatics.
    Boggs PB; Bhat KD; Vekovius WA; Debo MS
    Ann Allergy; 1982 Mar; 48(3):139-42. PubMed ID: 7065476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical benefits of 7 years of treatment with omalizumab in severe uncontrolled asthmatics.
    Pace E; Ferraro M; Bruno A; Chiappara G; Bousquet J; Gjomarkaj M
    J Asthma; 2011 May; 48(4):387-92. PubMed ID: 21391878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FEF75 in asthma management.
    Luigi DB; Emanuel DT; Federica DB; Fabrizio DT
    Eur Ann Allergy Clin Immunol; 2007 Dec; 39(10):333-6. PubMed ID: 18386434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung function decline in asthma.
    Sears MR
    Eur Respir J; 2007 Sep; 30(3):411-3. PubMed ID: 17766631
    [No Abstract]   [Full Text] [Related]  

  • 17. Determining the time to maximal bronchodilator response in asthmatic children.
    Stavreska V; Verheggen M; Oostryck J; Stick SM; Hall GL
    J Asthma; 2009 Feb; 46(1):25-9. PubMed ID: 19191133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung function at 10 yrs is not improved by early corticosteroid treatment in asthmatic children.
    Lødrup Carlsen KC; Devulapalli CS; Mowinckel P; Håland G; Munthe-Kaas MC; Carlsen KH
    Pediatr Allergy Immunol; 2010 Aug; 21(5):814-22. PubMed ID: 19912549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled steroids are associated with reduced lung function decline in subjects with asthma with elevated total IgE.
    de Marco R; Marcon A; Jarvis D; Accordini S; Bugiani M; Cazzoletti L; Cerveri I; Corsico A; Gislason D; Gulsvik A; Jõgi R; Martínez-Moratalla J; Pin I; Janson C;
    J Allergy Clin Immunol; 2007 Mar; 119(3):611-7. PubMed ID: 17258304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of the effect of yoga training on pulmonary functions in patients with bronchial asthma.
    Sodhi C; Singh S; Dandona PK
    Indian J Physiol Pharmacol; 2009; 53(2):169-74. PubMed ID: 20112821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.